Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Revaree Plus in Women With Breast Cancer

NCT07042581 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT07042581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07042581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Revaree Plus in Women With Breast Cancer
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Phase 4
Overall status
Recruiting
Start date
June 20, 2025
Completion date
June 20, 2029
Enrollment
60 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, hormone receptor positive breast carcinoma, hormone receptor positive malignant neoplasm of breast, hormone-receptor-positive breast cancer, stage 0 breast cancer, stage 0 breast carcinoma, stage i breast cancer, stage ii breast cancer, stage ii breast carcinoma, stage iii breast cancer, stage iii breast carcinoma